Table 2 Characteristics of the LNA GapmeRs used in the study
From: CVD-associated SNPs with regulatory potential reveal novel non-coding disease genes
ID | Sequence (5′–3′) |
|---|---|
GapmeR negative Control | AACACGTCTATACGC |
GapmeR RP11-98F14.11 #1 | CGCGTGCTTCAATTTA |
GapmeR RP11-98F14.11 #2 | CTCCGCGTGCTTCAAT |
GapmeR RP11-98F14.11 #3 | CTGAGAAGGCGCTGAT |
GapmeR RP11-98F14.11 #4 | TCGCTGAGAAGGCGCT |
GapmeR RPL23AP92 #1 | TTGGTCGCATAGTGGT |
GapmeR RPL23AP92 #2 | TTTTGACCTCGACATC |
GapmeR RPL23AP92 #3 | CGACATCCACAATGAA |
GapmeR RPL23AP92 #4 | GCTTTTTGACCTCGAC |
GapmeR IGBP1P1 #1 | TGGCGAGATGAATTAG |
GapmeR IGBP1P1 #2 | GGATAAGCCATGGAGA |
GapmeR IGBP1P1 #3 | GAAATTAGCAGTGTGA |
GapmeR IGBP1P1 #4 | GCAATGAGGCTAGGAT |
GapmeR CTD-2383I20.1 #1 | GAAGGTTGGTCGTCTT |
GapmeR CTD-2383I20.1 #2 | GTTGGTCGTCTTGGTT |
GapmeR CTD-2383I20.1 #3 | CTTGCCAGCATCTGAT |
GapmeR CTD-2383I20.1 #4 | AACAAGCTGGCCATTT |